Naltrexone Treatment for Alcoholic Women

Completed · Phase 4 · Has a placebo group

Conditions studied: Alcoholism, Eating Disorder

In brief

This study will assess naltrexone's effectiveness in treating alcoholism in women and provide information on its potential value in treating eating disorders common among alcoholic women. Alcoholic women with and without both eating disorders and depression will be randomly assigned to placebo or naltrexone treatment. Each group will receive behavioral therapy for 12 weeks, with followup 6 months after treatment.

Key facts

Study ID
NCT00000448
Run by
Yale University
People needed
160
Starts
1995-10-01
Expected to finish
2000-12-01
Last updated by the study team
2014-05-07

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.